Protective effects of non-anticoagulant activated protein C variant (D36A/L38D/A39V) in a murine model of ischaemic stroke.
Ischaemic stroke is caused by occlusive thrombi in the cerebral vasculature. Although tissue-plasminogen activator (tPA) can be administered as thrombolytic therapy, it has major limitations, which include disruption of the blood-brain barrier and an increased risk of bleeding. Treatments that preve...
Main Authors: | Anna P Andreou, Maria Efthymiou, Yao Yu, Helena R Watts, Faruq H Noormohamed, Daqing Ma, David A Lane, James T B Crawley |
---|---|
格式: | 文件 |
语言: | English |
出版: |
Public Library of Science (PLoS)
2015-01-01
|
丛编: | PLoS ONE |
在线阅读: | http://europepmc.org/articles/PMC4382112?pdf=render |
相似书籍
-
Ischaemic stroke in patients treated with oral anticoagulants
由: L.M. Cano, et al.
出版: (2016-07-01) -
Thrombolysis for ischaemic stroke despite direct oral anticoagulation
由: Ying Xian, et al. -
Struktuur en strekking van Job 38:39–39:30
由: L. C. Bezuidenhout
出版: (1987-01-01) -
Raja – 19, 32, 38 ja 39
由: Pekka Niskanen
出版: (2017-03-01) -
Recurrence of LV Thrombus in a Patient with Severe Ischaemic Cardiomyopathy Anticoagulated with Apixaban
由: Azhar Farooqui, et al.
出版: (2022-01-01)